These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 4190916)

  • 1. Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.
    Alexander WD; McLarty DG; Robertson J; Shimmins J; Brownlie BE; Harden RM; Patel AR
    J Clin Endocrinol Metab; 1970 Apr; 30(4):540-3. PubMed ID: 4190916
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.
    Hales I; Stiel J; Reeve T; Heap T; Myhill J
    J Clin Endocrinol Metab; 1969 Jul; 29(7):998-1001. PubMed ID: 4183236
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyroidal suppressibility after stopping long-term treatment of thyrotoxicosis with anti-thyroid drugs.
    Alexander WD; Harden RM; McLarty D; Shimmins J
    Metabolism; 1969 Jan; 18(1):58-62. PubMed ID: 4179400
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical diagnosis of thyrotoxicosis].
    Wiggers S; Amtoft A; Kjaer J; Nielsen ES; Jensen OB
    Ugeskr Laeger; 1970 Oct; 132(44):2064-7. PubMed ID: 4098486
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppressibility of thyroid function during treatment with antithyroid drugs in Grave's disease.
    Wils JA; Kloppenborg PW
    J Clin Endocrinol Metab; 1970 Mar; 30(3):406-7. PubMed ID: 4189571
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma glycerol and glycerol turnover during treatment of hyperthyroidism.
    Tibbling G; Cederquist E; Lundquist A
    Clin Chim Acta; 1969 Aug; 25(2):189-98. PubMed ID: 4184576
    [No Abstract]   [Full Text] [Related]  

  • 7. [The inhibition test of thyroid function with triiodothyronine in hyperthyroid patients under medical therapy: comparison of the values obtained from measures of "early" uptake and in the organic phase].
    Valentini F; Reschini E; Lodeserto A; Vivarelli S; Miedico D
    Folia Endocrinol; 1968 Aug; 21(4):396-403. PubMed ID: 4185869
    [No Abstract]   [Full Text] [Related]  

  • 8. Iodine organification defect following treatment of thyrotoxicosis with antithyroid drugs.
    Horton PW; Millar WT; McLarty DG; Alexander WD
    Clin Endocrinol (Oxf); 1975 Jul; 4(4):357-62. PubMed ID: 168992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine distribution in thyroid tissue taken from hyperthyroid patients treated with Lugol's solution or carbimazole.
    Etling N
    Rev Eur Etud Clin Biol; 1971; 16(7):662-7. PubMed ID: 4107371
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative studies of iodine metabolism after long-term treatment of thyrotoxicosis with antithyroid drugs.
    Harden RM; Alexander WD; Koutras DA; Harrison MT; Wayne E
    J Clin Endocrinol Metab; 1966 Apr; 26(4):397-401. PubMed ID: 4160410
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of thyrotoxicosis with lithium carbonate.
    Lazarus JH; Richards AR; Addison GM; Owen GM
    Lancet; 1974 Nov; 2(7890):1160-3. PubMed ID: 4139588
    [No Abstract]   [Full Text] [Related]  

  • 12. Antithyroid drug therapy in hyperthyroidism. Recurrence, hypothyroidism and thyroid antibodies.
    Stege R
    Acta Chir Scand Suppl; 1980; 501():1-130. PubMed ID: 6163270
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyroid suppression test as index of outcome of hyperthyroidism treated with antithyroid drugs.
    Cassidy CE
    Metabolism; 1970 Oct; 19(10):745-50. PubMed ID: 4096944
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of thyroid function during and after treatment of thyrotoxicosis.
    McLarty DG; Alexander WD
    J Clin Pathol; 1975 Mar; 28(3):251-4. PubMed ID: 47343
    [No Abstract]   [Full Text] [Related]  

  • 15. Neonatal thyrotoxicosis.
    Hopton DS; Wade JS
    Proc R Soc Med; 1969 Aug; 62(8):817. PubMed ID: 4185737
    [No Abstract]   [Full Text] [Related]  

  • 16. Thyroidal suppression by triiodothyronine as a guide to duration of treatment of thyrotoxicosis with antithyroid drugs.
    Alexander WD; Harden RM; Shimmins J
    Lancet; 1966 Nov; 2(7472):1041-4. PubMed ID: 4162502
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-term effects of anti-thyroid agents in thyrotoxicosis (author's transl)].
    Laroche C; Remy JM; Letellier P
    Ann Endocrinol (Paris); 1974; 35(1):67-8. PubMed ID: 4138459
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of thyroidal suppression by triiodothyronine during six months' treatment of thyrotoxicosis with antithyroid drugs.
    Alexander WD; Harden RM; Shimmins J; McLarty D; McGill P
    J Clin Endocrinol Metab; 1967 Dec; 27(12):1682-9. PubMed ID: 4168655
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical significance of determination of early thyroidal 131-I uptake rate--relationship with 24-hour 131-I uptake rate].
    Nagataki S; Uchimura H; Irie M; Tsushima T; Masuyama H
    Horumon To Rinsho; 1972 Feb; 20(2):107-14. PubMed ID: 4112484
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyroid function after treatment of hyperthyroidism.
    Lancet; 1975 Sep; 2(7935):590-1. PubMed ID: 51412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.